
Phreesia Inc (PHR) Stock Forecast & Price Target
Phreesia Inc (PHR) Analyst Ratings
Bulls say
Phreesia is in a strong financial position, with a strengthened balance sheet and a solid cash position. The company has a diverse customer base and offers a suite of solutions to address key challenges in healthcare delivery. By maintaining a strong focus on reinvesting in the core business and paying down debt, management is positioning the company for sustained growth. The recent launch of Provider Connect and PlanMatch, along with more bullish outlook on the Clips) can result in higher revenue and EBITDA estimates for FY27 and FY28. Overall, Phreesia is a dominant player in a growing digital health market and presents an attractive risk/reward profile for long-term investors.
Bears say
Phreesia is heavily dependent on a relatively new and unproven market in the healthcare industry, and if they are unable to successfully promote the benefits of their platform, growth may be limited. Additionally, the company must constantly adapt to rapidly changing industry standards and technology, and if they are unable to keep up with competitors, their services may become obsolete. The company's success also relies on increasing patient engagement and demand for their services, which could be impacted by economic conditions and shifting healthcare spending priorities. Furthermore, the company is at risk of integration challenges and faces competition from others with greater resources. Based on the company's recent financial performance and market conditions, the bear case scenario values the stock at $8 per share, and the base case scenario values it at $14 per share. Overall, there are significant risks facing Phreesia, and the analyst maintains a negative outlook on the stock.
This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares